title: Chemical matrixectomy for ingrown toenails: Is there an evidence basis to guide therapy?
abstract: Chemical matrixectomy for ingrown toenails is one of the most common surgical procedures performed on the foot. The procedure was first described in 1945 by Otto Boll, who discussed the use of phenol to correct ingrown toenails. In the years that followed, many variations of technique and method have been described. This article reviews the pertinent literature detailing chemical matrixectomies and advocates the use of an evidence basis for care.
authors.affiliation: Department of Surgery, Podiatry Section, Southern Arizona Veterans Affairs Medical Center, Tucson 85710, USA.
authors.forename: Eric H
authors.initials: EH
authors.lastname: Espensen
authors.forename: Brent P
authors.initials: BP
authors.lastname: Nixon
authors.forename: David G
authors.initials: DG
authors.lastname: Armstrong
mesh_terms: D017719:Diabetic Foot / Q000150:complications; D019317:Evidence-Based Medicine; D006801:Humans; D009263:Nails, Ingrown / Q000150:complications / Q000628:therapy*; D018579:Patient Selection; D019800:Phenol / Q000627:therapeutic use*; D012307:Risk Factors; D012972:Sodium Hydroxide / Q000627:therapeutic use; D014034:Toes
chemical_list: D019800:Phenol; D012972:Sodium Hydroxide